Canada markets open in 1 hour 46 minutes

Avisa Diagnostics Inc. (AVBT.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.04500.0000 (0.00%)
At close: 03:53PM EST
Full screen
Previous Close0.0450
Open0.0000
Bid0.0400 x N/A
Ask0.0400 x N/A
Day's Range0.0450 - 0.0450
52 Week Range0.0300 - 1.1250
Volume0
Avg. Volume17,023
Market Cap123,658
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IIROC Trading Halt - AVBT

    The following issues have been halted by IIROC:

  • GlobeNewswire

    Avisa Diagnostics Reports on Status of Interim Filings

    SANTA FE, N.M. and MALVERN, Pa., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” or the “Company”), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, reports that, due to current liquidity limitations, the Company does not anticipate that it will be able to file its unaudited financial statements for the period ended September 30, 2021, related

  • GlobeNewswire

    Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer

    Experienced Industry pulmonologist brings decades of respiratory experienceSANTA FE, N.M. and MALVERN, Pa., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, is pleased to announce that the Company has hired Richard K. Murray, M.D., to the newly created position of Chief Medical Officer (CMO). Dr